Platelet-monocyte complex formation: Effect of blocking PSGL-1 alone, and in combination with αiIbβ3 and αmβ2, in coronary stenting

Thrombosis Research

Volumn 111, Issue 3, 2003, Pages 171-177

  Fernandes, Laura S ^a   Conde, Ian D ^a   Smith, C Wayne ^a   Kansas, Geoffrey S ^b   Snapp, Karen R ^c   Bennet, Nelson ^a   Ballantyne, Christie ^a   McIntire, Larry V ^d   Smith, E O'Brian ^a   Klem, Jeffrey A ^a   Mathew, Shiba ^a   Frangogiannis, Nikolaos ^a   Turner, Nancy A ^d   Maresh, Kelley J ^a   Kleiman, Neal S ^a,e  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^d RICE UNIVERSITY   (United States)

^e HOUSTON METHODIST HOSPITAL   (United States)

Author keywords

Monocyte; P selectin; Platelet; PSGL 1

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; CD11B ANTIGEN; CLOPIDOGREL; EPTIFIBATIDE; FIBRINOGEN RECEPTOR; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; INTEGRILLIN; INTEGRIN; P SELECTIN GLYCOPROTEIN LIGAND 1;

ADULT; ARTICLE; CELL INTERACTION; CELL STIMULATION; CLINICAL ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; CORONARY STENT; FLOW CYTOMETRY; HEART MUSCLE ISCHEMIA; HUMAN; LEUKOCYTE; MALE; MONOCYTE; PRIORITY JOURNAL; THROMBOCYTE; THROMBOSIS; VOLUNTEER;

EID: 0346849877     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2003.08.017     Document Type: Article

References (29)

1. Ott I., Neumann F.J., Gawaz M., Schmitt M., Schomig A. Increased neutrophil-platelet adhesion in patients with unstable angina. Circulation. 94(6):1996;1239-1246.
2. Neumann F.J., Zohlnhofer D., Fakhoury L., Ott I., Gawaz M., Schomig A. Effect of glycoprotein IIb/IIIa receptor blockade on platelet-leukocyte interaction and surface expression of the leukocyte integrin Mac-1 in acute myocardial infarction. J. Am. Coll Cardiol. 34(5):1999;1420-1426.
3. May A.E., Neumann F.J., Gawaz M., Ott I., Walter H., Schomig A. Reduction of monocyte-platelet interaction and monocyte activation in patients receiving antiplatelet therapy after coronary stent implantation. Eur. Heart J. 18(12):1997;1913-1920.
4. Mickelson J.K., Lakkis N.M., Villarreal-Levy G., Hughes B.J., Smith C.W. Leukocyte activation with platelet adhesion after coronary angioplasty: a mechanism for recurrent disease? J. Am. Coll Cardiol. 28(2):1996;345-353.
5. Berman C.L., Yeo E.L., Wencel-Drake J.D., Furie B.C., Ginsberg M.H., Furie B. A platelet alpha granule membrane protein that is associated with the plasma membrane after activation. Characterization and subcellular localization of platelet activation-dependent granule-external membrane protein. J. Clin. Invest. 78(1):1986;130-137.
6. Sako D., Chang X.J., Barone K.M., Vachino G., White H.M., Shaw G.et al. Expression cloning of a functional glycoprotein ligand for P-selectin. Cell. 75(6):1993;1179-1186.
7. Yang J., Hirata T., Croce K., Merrill-Skoloff G., Tchernychev B., Williams E.et al. Targeted gene disruption demonstrates that P-selectin glycoprotein ligand 1 (PSGL-1) is required for P-selectin-mediated but not E-selectin-mediated neutrophil rolling and migration. J. Exp. Med. 190(12):1999;1769-1782.
8. Celi A., Pellegrini G., Lorenzet R., DeBlasi A., Ready N., Furie B.C.et al. P-selectin induces the expression of tissue factor on monocytes. Proc. Natl. Acad. Sci. U. S. A. 91(19):1994;8767-8771.
9. Lindmark E., Tenno T., Siegbahn A. Role of platelet P-selectin and CD40 ligand in the induction of monocytic tissue factor expression. Arterioscler. Thromb. Vasc. Biol. 20(10):2000;2322-2328.
10. Weyrich A.S., McIntyre T.M., McEver R.P., Prescott S.M., Zimmerman G.A. Monocyte tethering by P-selectin regulates monocyte chemotactic protein-1 and tumor necrosis factor-alpha secretion. Signal integration and NF- kappa B translocation. J. Clin. Invest. 95(5):1995;2297-2303.
11. Weyrich A.S., Elstad M.R., McEver R.P., McIntyre T.M., Moore K.L., Morrissey J.H.et al. Activated platelets signal chemokine synthesis by human monocytes. J. Clin. Invest. 97(6):1996;1525-1534.
12. Koike J., Nagata K., Kudo S., Tsuji T., Irimura T. Density-dependent induction of TNF-alpha release from human monocytes by immobilized P-selectin. FEBS Lett. 477(1-2):2000;84-88.
13. Tsuji T., Nagata K., Koike J., Todoroki N., Irimura T. Induction of superoxide anion production from monocytes an neutrophils by activated platelets through the P selectin-sialyl Lewis X interaction. J. Leukoc. Biol. 56(5):1994;583-587.
14. Evangelista V., Manarini S., Sideri R., Rotondo S., Martelli N., Piccoli A.et al. Platelet/polymorphonuclear leukocyte interaction: P-selectin triggers protein-tyrosine phosphorylation-dependent CD11b/CD18 adhesion: role of PSGL-1 as a signaling molecule. Blood. 93(3):1999;876-885.
15. Bienvenu J.G., Tanguay J.F., Theoret J.F., Kumar A., Schaub R.G., Merhi Y. Recombinant soluble p-selectin glycoprotein ligand-1-Ig reduces restenosis through inhibition of platelet-neutrophil adhesion after double angioplasty in swine. Circulation. 103(8):2001;1128-1134.
16. Tanguay J.F.et al. Recombinant soluble P-selectin glycoprotein ligand-1 (rPSGL-Ig) inhibits in-stent restenosis in porcine coronary arteries after double injury. XVIII Congress of The International Society on Thrombosis and Haemostasis. 2001;. (July).
17. Wang K., Zhou Z., Zhou X., Tarakji K., Topol E.J., Lincoff A.M. Prevention of intimal hyperplasia with recombinant soluble P-selectin glycoprotein ligand-immunoglobulin in the porcine coronary artery balloon injury model. J. Am. Coll Cardiol. 38(2):2001;577-582.
18. Rogers C., Edelman E.R., Simon D.I. A mAb to the beta2-leukocyte integrin Mac-1 (CD11b/CD18) reduces intimal thickening after angioplasty or stent implantation in rabbits. Proc. Natl. Acad. Sci. U. S. A. 95(17):1998;10134-10139.
19. Snapp K.R., Ding H., Atkins K., Warnke R., Luscinskas F.W., Kansas G.S. A novel P-selectin glycoprotein ligand-1 monoclonal antibody recognizes an epitope within the tyrosine sulfate motif of human PSGL-1 and blocks recognition of both P- and L-selectin. Blood. 91(1):1998;154-164.
20. Alevriadou B.R., Moake J.L., Turner N.A., Ruggeri Z.M., Folie B.J., Phillips M.D.et al. Real-time analysis of shear-dependent thrombus formation and its blockade by inhibitors of von Willebrand factor binding to platelets. Blood. 81(5):1993;1263-1276.
21. Kuijper P.H., GallardoTorres H.I., van der Linden J.A., Lammers J.W., Sixma J.J., Koenderman L.et al. Platelet-dependent primary hemostasis promotes selectin- and integrin-mediated neutrophil adhesion to damaged endothelium under flow conditions. Blood. 87(8):1996;3271-3281.
22. Weber C., Springer T.A. Neutrophil accumulation on activated, surface-adherent platelets in flow is mediated by interaction of Mac-1 with fibrinogen bound to alphaIIbbeta3 and stimulated by platelet-activating factor. J. Clin. Invest. 100(8):1997;2085-2093.
23. Fredrickson B.J., Turner N.A., Kleiman N.S., Graziadei N., Maresh K., Mascelli M.A.et al. Effects of abciximab, ticlopidine, and combined abciximab/ticlopidine therapy on platelet and leukocyte function in patients undergoing coronary angioplasty. Circulation. 101(10):2000;1122-1129.
24. Schneider D.J., Taatjes D.J., Sobel B.E. Paradoxical inhibition of fibrinogen binding and potentiation of alpha-granule release by specific types of inhibitors of glycoprotein IIb-IIIa. Cardiovasc. Res. 45(2):2000;437-446.
25. Zhao L., Bath P.M., Fox S., May J., Judge H., Losche W.et al. The effects of GPIIb-IIIa antagonists and a combination of three other antiplatelet agents on platelet-leukocyte interactions. Curr. Med. Res. Opin. 19(3):2003;178-186.
26. Sanderson H.M., Fox S.C., Robbins R.A., Losche W., Spangenberg P., Heptinstall S. Role of GPIIb-IIIa in platelet-monocyte and platelet-neutrophil conjugate formation in whole blood. Platelets. 9:1998;245-250.
27. Phillips D.R., Nannizzi-Alaimo L., Prasad K.S. Beta3 tyrosine phosphorylation in alphaIIbbeta3 (platelet membrane GP IIb-IIIa) outside-in integrin signaling. Thromb. Haemost. 86(1):2001;246-258.
28. Peter K., Schwarz M., Ylanne J., Kohler B., Moser M., Nordt T.et al. Induction of fibrinogen binding and platelet aggregation as a potential intrinsic property of various glycoprotein IIb/IIIa (alphaIIbbeta3) inhibitors. Blood. 92(9):1998;3240-3249.
29. Plescia J., Conte M.S., VanMeter G., Ambrosini G., Altieri D.C. Molecular identification of the cross-reacting epitope on alphaM beta2 integrin I domain recognized by anti-alphaIIb beta3 monoclonal antibody 7E3 and its involvement in leukocyte adherence. J. Biol. Chem. 273(32):1998;20372-20377.